Tibet Pharma Observers Not Liable In IPO Row, 3rd Circ. Told
Two defendants in a class action accusing Tibet Pharmaceuticals Inc. of misleading investors about its financial health before its 2011 initial public offering urged the Third Circuit to toss the last...To view the full article, register now.
Already a subscriber? Click here to view full article